Of the specific NY 157-165-CD8+ T-cell lines generated with either peptide-pulsed DCs or whole-antigen-loaded DCs, only 12% were capable of recognizing the SK-MEL37 tumor-cell line. This evidence concerns the gene CD8A and neoplasm.